Braveheart Bio reportedly pricing IPO above marketing range
Go back to Braveheart Bio reportedly pricing IPO above marketing range| (NASDAQ: BRVE) | Delayed: 26.28 +0.78 (3.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.50 | 52 Week High | $ | |||
| Open | $25.76 | 52 Week Low | $ | |||
| Day High | $27.06 | P/E | N/A | |||
| Day Low | $24.90 | EPS | $ | |||
| Volume | 342,871 | |||||

